Drug Shortage Report for APO-SAXAGLIPTIN

Last updated on 2022-01-14 History
Report ID 152773
Drug Identification Number 02507471
Brand name APO-SAXAGLIPTIN
Common or Proper name SAXAGLIPTIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) SAXAGLIPTIN
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BLS
ATC code A10BH
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-10
Estimated end date 2022-02-02
Actual end date
Shortage status Actual shortage
Updated date 2022-01-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-01-14 French Compare
v1 2022-01-14 English Compare

Showing 1 to 2 of 2